InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Brannan Stephen K., Directeur Médical. Insider active across 1 companies, notably Karuna Therapeutics, Inc.. Aggregated, 12 disclosures have been logged. The latest transaction was filed on 9 June 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
€43,3185,000 shares@ €8.663520.9% of flow
Common Stock
SEC:0001593968-22-001097:0·
€43,5375,000 shares@ €8.707321.0% of flow
Common Stock
SEC:0001593968-22-000944:0·
€12,3052,500 shares@ €4.92225.9% of flow
Common Stock
SEC:0001593968-22-000822:0·
€12,1482,500 shares@ €4.85925.9% of flow
Common Stock
SEC:0001593968-22-000601:0·
€12,1332,500 shares@ €4.853225.3% of flow
Common Stock
SEC:0001593968-22-000363·
€12,1332,500 shares@ €4.85325.9% of flow
Common Stock
SEC:0001593968-22-000363:0·
€11,9802,500 shares@ €4.791925.0% of flow
Common Stock
SEC:0001593968-22-000018·
€11,9802,500 shares@ €4.79195.8% of flow
Common Stock
SEC:0001593968-22-000018:0·
€12,0252,500 shares@ €4.810125.1% of flow
Common Stock
SEC:0001593968-21-002516·
€12,0252,500 shares@ €4.81015.8% of flow
Common Stock
SEC:0001593968-21-002516:0·
€11,7902,500 shares@ €4.715924.6% of flow
Common Stock
SEC:0001593968-21-002356·
€11,7902,500 shares@ €4.71595.7% of flow
Common Stock
SEC:0001593968-21-002356:0·
12 of 12 declarations
About Brannan Stephen K.
Stephen K. Brannan is the Chief Medical Officer of Karuna Therapeutics, Inc. In this role, he is responsible for the medical direction of the company, overseeing research and development activities related to therapeutic products. His expertise in medicine and biotechnology is essential for guiding clinical initiatives and ensuring that the treatments developed meet the highest standards of safety and efficacy.
